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A B S T R A C T
Abnormalities in responses to human facial emotions are associated with a range of psychiatric disorders.
Addressing these abnormalities may therefore have signiﬁcant clinical applications. Previous meta-analyses have
demonstrated eﬀects of the neuropeptide oxytocin on behavioural response to facial emotions, and eﬀects on
brain, as measured by functional MRI. Evidence suggests that these eﬀects may be mediated by sex and the role
of eye gaze. However, the speciﬁc eﬀect of oxytocin on brain response to facial emotions in healthy adults has
not been systematically analysed. To address this question, this further systematic review was conducted.
Twenty-two studies met our inclusion criteria. In men, oxytocin consistently attenuated brain activity in re-
sponse to negative emotional faces, particularly fear, compared with placebo, while in women, oxytocin en-
hanced activity. Brain regions consistently involved included the amygdala, fusiform gyrus and anterior cin-
gulate cortex. In some studies, oxytocin increased ﬁxation changes towards the eyes with enhanced amygdala
and/or fusiform gyrus activation. By enhancing understanding of emotion processing in healthy subjects, these
pharmacoimaging studies provide a theoretical basis for studying deﬁcits in clinical populations. However,
progress to date has been limited by low statistical power, methodological heterogeneity, and a lack of multi-
modal studies.
1. Introduction
Emotion recognition is a central component of social cognition. It
provides the capacity to understand the intentions, feelings, and reac-
tions of others (Shahrestani et al., 2013). Emotion recognition has been
linked to altruistic helping behaviour (Marsh et al., 2007) and higher
relationship quality with a lower rate of depression (Carton et al.,
1999). In contrast, deﬁcits in emotion recognition are associated with
increased social anxiety and avoidance and antisocial behaviour as well
as psychiatric disorders including schizophrenia, depression, autism
spectrum disorders (ASD) and psychopathy (Chung et al., 2013;
McClure and Nowicki Jr, 2001; McClure et al., 2014; Uljarevic and
Hamilton, 2013). Furthermore, social cognitive deﬁcits, including
emotion recognition, predict social function in both early psychosis
(Bertrand et al., 2007) and autism (Losh et al., 2009) above other tests
of neurocognition. Emotion recognition has been investigated in func-
tional neuroimaging studies by analysing neural response to facial
emotions, alongside behavioural measures. Brain regions identiﬁed by
meta-analyses of functional neuroimaging studies as having a role in
response to facial emotions include globus pallidus, lateral orbitofrontal
cortex, medial prefrontal cortex, subcallosal cingulate and most con-
sistently, the amygdala, anterior cingulate cortex (ACC) and the insula.
(Murphy et al., 2003; Phan et al., 2002).
Oxytocin is a neuropeptide central to the regulation of complex
social cognition and behaviours, such as attachment, social exploration,
and recognition. For example, in prairie voles, oxytocin plays a key role
in pair bond formation (Young and Wang, 2004) and reducing fear in
social interactions (Carter et al., 2008). In healthy humans, oxytocin
binds to receptors in social brain regions such as the amygdala and ACC
(Boccia et al., 2013) and plays a key role in social brain functions such
as modulation of social stress, emotion recognition and memory for-
mation (Meyer-Lindenberg et al., 2011). Oxytocin has also been shown
to exert modulatory eﬀects on brain activity in people with mental
disorders. For instance, in women with borderline personality disorder,
oxytocin attenuates abnormal behavioural and amygdala processing of
emotional stimuli (Bertsch et al., 2013). In autism, some (Anagnostou
et al., 2012; Andari et al., 2010; Guastella et al., 2010; Hollander et al.,
2007), albeit not all (Dadds et al., 2014), studies have reported that
oxytocin improves emotion recognition, and modulates activity in the
medial prefrontal cortex (Aoki et al., 2015; Watanabe et al., 2013).
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The impact of oxytocin on behavioural and brain response to facial
emotions has typically been evaluated experimentally using a single
dose of intranasal oxytocin given 30–45 min before behavioural ex-
periments (Guastella and MacLeod, 2012). Some studies have suggested
that oxytocin speciﬁcally improves the perception of happy faces,
(Marsh et al., 2007; Schulze et al., 2011), while others report that
oxytocin improves the recognition of angry, sad, and fearful emotions
in faces (Ellenbogen et al., 2012; Fischer-Shofty et al., 2010; Lischke
et al., 2012a). Guastella and MacLeod (2012) have argued that diﬀer-
ences in methodologies or samples between studies may contribute to
such inconsistent ﬁndings. It should also be noted that recent reviews of
the oxytocin literature (Quintana, 2018; Walum et al., 2016) have
highlighted that many studies of behavioural eﬀects are underpowered,
and have made recommendations to improve the reliability of oxytocin
research and identify more promising avenues for future work. These
include employing equivalence tests in statistical analysis (Quintana,
2018), performing a priori power calculations, disclosing methods and
ﬁndings transparently, and working collaboratively to increase power
and replicate ﬁndings (Walum et al., 2016).
Notwithstanding these concerns, a meta-analysis of the eﬀects of
single dose oxytocin on recognition of facial emotions in healthy sub-
jects showed that intranasal oxytocin administration enhances emotion
recognition of faces overall (Hedges g eﬀect size 0.29) (Shahrestani
et al., 2013). When analysis was restricted to facial expression types,
signiﬁcant eﬀects of oxytocin on recognition accuracy were speciﬁcally
found for the recognition of happy and fearful faces. A further recent
meta-analysis demonstrated that a single dose of intranasal oxytocin
signiﬁcantly improved the recognition of basic emotions, particularly
fear, among healthy individuals (Leppanen et al., 2017).
While these are interesting ﬁndings, neurocognitive or behavioural
studies do not demonstrate underlying activity in the brain, the sub-
strate for any potential therapeutic modulation. In contrast, using
functional imaging to elucidate which brain regions are aﬀected by
oxytocin can demonstrate a neural underpinning for its eﬀects. Applied
to mental disorders, this approach may be used to demonstrate diﬀer-
ential modulation of brain compared to healthy controls and help
identify treatment targets and pathways into and pathways out of these
disorders. Further, many neuroimaging studies utilise paradigms which
measure ‘implicit’ processing of facial emotions. Such tasks require
participants simply to identify the sex of faces presented, or stay fo-
cused on the face, rather than explicity identifying the emotion. This
may have the added beneﬁt of removing variance caused by participant
eﬀort on behavioural tasks (Bethlehem et al., 2013).
Furthermore, several studies have called into question the supposed
‘prosocial’ eﬀects of oxytocin (Bartz et al., 2011; De Dreu et al., 2011a,
2010, 2011b) and suggested likely mediation of its eﬀects by social
context (Bartz et al., 2011) and other social (Heinrichs et al., 2003;
Meinlschmidt and Heim, 2007; Saphire-Bernstein et al., 2011;
Strathearn et al., 2009) physiological (Cardoso et al., 2013; Ditzen
et al., 2009; Norman et al., 2012), and genetic (Feldman et al., 2013;
Kim et al., 2010; Marsh et al., 2012; Rodrigues et al., 2009; Saphire-
Bernstein et al., 2011; Tost et al., 2010, 2011; Walum et al., 2012)
factors. Functional imaging may therefore also have a role in eluci-
dating diﬀerential neural mechanisms underlying these confounding
variables. Particularly relevant to processing of facial emotion re-
cognition may be eye-gaze, which is an important factor in classifying
facial expressions (Haxby et al., 2002; Smith et al., 2005) and has been
shown to be aﬀected by oxytocin (Domes et al., 2013) and mediated by
the amygdala (Gamer and Büchel, 2009).
Two recent meta-analyses of FMRI studies have demonstrated that,
in healthy controls, intranasal administration of oxytocin resulted in
consistent alterations in activation of brain regions, including the
amygdala, temporal lobes, ACC and insula, during the processing of a
range of social stimuli, not exclusive to facial emotions (Wang et al.,
2017; Wigton et al., 2015). The aim of our review was to systematically
analyse the evidence speciﬁcally for modulation of neural processing of
facial emotions by oxytocin, as measured by fMRI, in healthy controls.
We discuss the speciﬁc eﬀects of oxytocin on processing of individual
emotions, as examined by some of the studies. We discuss mediation of
oxytocin's eﬀects by sex and speciﬁc emotion. We consider the potential
impact of use of implicit vs explicit paradigms. We also consider ap-
parent discrepancies in hemispheric lateralisation and brain regions
identiﬁed across studies. Finally, we discuss the eﬀects of oxytocin on
gaze processing and the role of genetic polymorphisms, as examined by
some of these studies.
2. Methods
2.1. Search strategy
We used a systematic search strategy following the PRISMA guide-
lines for systematic reviews (Moher et al., 2009) to identify relevant
studies for inclusion in our review. The databases used were MEDLINE
(PubMed), Web of Science and The Cochrane Central Register of Controlled
Trials (CENTRAL) Embase, ClinicalTrials.gov, PsychInfo, BioMed Cen-
tral, Google Scholar, and Scopus. Non-automated searching and cross
referencing of relevant publications was also conducted. Search terms
used were “Oxytocin” AND “fMRI OR functional magnetic resonance
imaging” AND “facial emotion recognition OR empathy task OR emo-
tion recognition OR facial expression OR valence task”. All studies
identiﬁed as meeting the pre-speciﬁed eligibility criteria were exported
to EndNote. Study abstracts were assessed for inclusion or exclusion by
three authors (JT, AG, DB). Full papers were obtained for studies which
met all inclusion criteria as outlined above. Papers published online up
until September 2017 were included. Although no limits were placed on
the language for an article, all articles found that ﬁt our selection cri-
teria were published in English.
2.2. Eligibility criteria
The primary outcome of interest for this review was the eﬀect of
oxytocin on response to facial emotions as measured by functional
magnetic resonance imaging (fMRI) in normal adult subjects. Studies
were selected on the basis that (i) participants were administered a
single dose of oxytocin intranasally, (ii) the eﬀect of intranasally ad-
ministered oxytocin on facial emotion processing was measured using
fMRI, and (iii) a facial emotion processing paradigm (or paradigms)
were used to measure the eﬀects of oxytocin on response to facial
emotions. We included studies using paradigms measuring both implicit
and explicit responses to facial emotions. Studies considered for selec-
tion were randomised controlled trials (RCT), cross-over studies, be-
tween-subject design studies and within-subjects design studies. Only
normal population adult subjects were included. Studies that used a
patient population but also reported ﬁndings for healthy controls were
included if they satisﬁed all other criteria. There were no restrictions on
sex. Exclusion criteria were postmortem studies, structural imaging
techniques, studies looking at only endogenous oxytocin or modes of
delivery other than intranasal, and studies examining response to facial
emotion tasks only (i.e. without fMRI).
2.3. GRADE scoring
To evaluate the quality of the evidence, GRADE scoring (Guyatt
et al., 2008) was employed. The GRADE system evaluates quality across
studies and speciﬁcally assesses methodological ﬂaws within the com-
ponent studies, consistency of results across diﬀerent studies, gen-
eralisability of research results to the wider patient base and how ef-
fective the treatments have been shown to be.
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3. Results
3.1. Samples, demographics, and study design
The results from the literature search are illustrated in the PRISMA
diagram (Fig. 1). Healthy control samples were male (n = 16 studies),
female (n = 4), or both male and female (n= 2) participants without
histories or signs of neurological, endocrine, psychiatric or serious so-
matic illnesses and not taking psychotropic medications.
Samples, demographics and key ﬁndings are outlined in Table 1.
Sample ages ranged on average from 19.66 years (± 1.45) to 39.3
years (± 6.2). Sample sizes ranged from 13 to 116 participants with a
total of 772 subjects from the combined studies (178 females) and an
average group size of 36.54 (note, two studies by Koch et al., 2016a,
2016b used the same sample, as did the studies by Sauer et al., 2012
and Montag et al., 2013). Sixteen studies examined healthy populations
only, while seven studied clinical populations but included healthy
controls. Of the twenty-two studies included, ten used a double-blind,
placebo controlled within-subject design and eleven used a double-
blind, placebo-controlled between-subject design. Spengler et al. (2017)
used a between-subjects design to compare doses and a crossover design
to compare times of dosing. Thirteen studies used a paradigm mea-
suring explicit response to facial emotions, while eight used a paradigm
measuring implicit response; Voorthuis et al. (2014) compared explicit
to implicit responses. Only seven studies used neutral facial expressions
as a speciﬁc contrast to emotional faces. The most frequently studied
emotions were happiness (seventeen studies), fear (fourteen) and anger
(eleven). Sadness, surprise, and disgust were each studied in two studies
only.
3.2. Key ﬁndings in relation to brain region, emotion type, sex and implicit
vs explicit paradigms
In the ﬁrst study of its kind, Kirsch et al. (2005) demonstrated that
oxytocin decreased amygdala activation in response to angry and
fearful faces in men. Several studies since have supported the hypoth-
esis that oxytocin attenuates brain activity in response to negative facial
emotions (fear, anger, disgust and sadness) in male samples. For ex-
ample, oxytocin reduced activity of the right amygdala in response to
fearful and angry faces (Domes et al., 2007); attenuated activation in
lateral and dorsal regions of the anterior amygdala (Gamer et al., 2010)
right amygdala, left ACC, left midtemporal gyrus (MTG) (Kanat et al.,
2015a) and left amygdala (Spengler et al., 2017) in response to fearful
faces/stimuli (eyes); reduced left and right amygdala responses to angry
stimuli (Kanat et al., 2015b); and decreased activity in the right ACC,
right middle frontal gyrus, right premotor and left superior parietal
cortex in response to sad vs neutral faces (Labuschagne et al., 2012).
Luo et al. (2017) showed that oxytocin reduced activity in left and right
ACC, left and right inferior frontal gyrus (IFG) to fearful faces, and left
and right IFG to angry faces and sad faces, all with a neutral contrast.
In contrast, in three studies with female subjects, oxytocin increased
brain activity in response to negative emotions. Domes et al. (2007)
demonstrated that oxytocin enhanced activity in the left amygdala,
fusiform gyrus and superior temporal gyrus in response to fearful faces
and in inferior frontal gyrus in response to angry faces in healthy
women, while Bertsch et al. (2013) demonstrated enhanced right,
centrally located amygdala activation in response to fearful faces with
oxytocin in their healthy controls. Luo et al. (2017) demonstrated in-
creased activity in response to oxytocin in right IFG to angry faces, left
ACC, left insula and left and right IFG to fearful faces, and left and right
IFG to sad faces. A notable exception to the patterns in males and fe-
males was the study by Koch et al. (2016b), which showed no sig-
niﬁcant main eﬀect of oxytocin on left and right amygdala reactivity
towards emotional faces in either sex.
Findings for brain responses to positive emotional faces (happiness)
were more equivocal. In studies in men, oxytocin variously reduced
activity of the right amygdala (Domes et al., 2007; Quintana et al.,
2016), bilateral amygdala (Shin et al., 2015), and right medial pre-
frontal cortex, right ACC, left middle frontal gyrus, left precuneus, left
fusiform gyrus, left calcarine ﬁssure and cerebellum (Labuschagne
Fig. 1. Study selection process (PRISMA).
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et al., 2012) in response to happy faces, but enhanced activation in
lateral and dorsal regions of the anterior amygdala (Gamer et al., 2010)
and right superior temporal gyrus (Labuschagne et al., 2012). In fe-
males, oxytocin led to signiﬁcantly stronger activation of the ventral
tegmental area to cues of high social reward (happy faces) and en-
hanced IFG in response to happy faces (Domes et al., 2010). Outcomes
based on implicit vs explicit facial emotion paradigms are shown in
Table 2, and implications are discussed below.
3.3. Functional connectivity and eye gaze
Kirsch et al. (2005) ﬁrst demonstrated that oxytocin decreased
amygdala connectivity to the brain stem in response to fearful and
angry faces in healthy subjects. Other studies including healthy subjects
have since demonstrated reduced connectivity in response to oxytocin
when responding to emotional faces. When processing happy, fearful
and angry faces, Gorka et al. (2015) demonstrated that oxytocin re-
duced amygdala connectivity to insula and mid/dorsal ACC, while Koch
et al. (2016a) demonstrated that oxytocin decreased right basolateral to
left dorsal ACC connectivity in males. Wittfoth-Schardt et al. (2012)
showed that oxytocin reduced functional connectivity of the left globus
pallidus with reward- and attachment-related regions responsive to
pictures of children's faces. Luo et al. (2017) showed sex-dependent
eﬀects on amygdala, ACC and IFG functional connectivity that were
mainly driven by reduced coupling in women following oxytocin.
However, Radke et al. (2017) found no oxytocin-induced alterations in
connectivity between regions examined (right anterior prefrontal cortex
and amygdala).
Five of the studies identiﬁed for this review examined the eﬀect of
eye gaze on outcome measures. In males, Petrovic et al. (2008) de-
monstrated abolition by oxytocin of diﬀerential negative aﬀective rat-
ings in faces exposed to an aversive conditioning. In amygdala and
fusiform gyrus, this modulation was stronger for faces with direct gaze,
relative to averted gaze, consistent with a relative speciﬁcity for so-
cially relevant cues. Gamer et al. (2010) demonstrated that oxytocin
increased the likelihood of reﬂexive gaze shifts toward the eye region
irrespective of the depicted emotional expression. Sauer et al. (2012)
showed that genotype (of OXTR) led to diﬀerential activation of left
fusiform gyrus activation during a gaze processing task. Analysing both
substance conditions separately led to a higher activation for A- carriers
compared with A+ under oxytocin, but not under placebo. Using the
same sample, in a further study exclusively examining the eﬀect of
oxytocin on eye gaze, Montag et al. (2013) showed that a separate
genetic variation of the OXTR gene (rs401015) modulated right
amygdala activity for direct vs averted gaze under inﬂuence of oxy-
tocin. This interaction was due to increased activation to directed gaze
and decreased activation to averted gaze under oxytocin in TC carriers.
In females, oxytocin resulted in enhanced right, more centrally located
amygdala activation in response to fearful faces with initial ﬁxation on
the eye region in those in the oxytocin condition. Only Domes et al.
(2010, also in females) failed to demonstrate a diﬀerential eﬀect of eye
gaze; their observed eﬀects of oxytocin were independent of ﬁxation
pattern to speciﬁc sections of the facial stimuli as revealed by eye
tracking.
3.4. GRADE scoring
An overall GRADE score of 1 (very low) was allocated to the current
review. This was based on:
– Type of evidence: evidence provided by RCTs (+4);
– Quality: problems with two ‘quality’ elements (sparse data and
methodological concerns) (−2);
– Consistency: problems with one ‘consistency’ element (lack of
agreement between studies) (−1).
– Directness: population and outcomes broadly generalizable (0);
– Eﬀect size: not all eﬀect sizes> 2 or< 0.5 and signiﬁcant; or if OR/
RR/HR not signiﬁcant (0).
4. Discussion
The aim of this review was to examine the evidence for modulation
by oxytocin of neural processing of responses to facial emotions, as
measured by fMRI. Previous reviews on the eﬀects of oxytocin on re-
sponse to facial emotion have focussed on eﬀects on task performance
only (Leppanen et al., 2017; Shahrestani et al., 2013), or more broadly
on oxytocin-neuroimaging studies (Bethlehem et al., 2013; Kanat et al.,
2014). Meta-analyses examining the eﬀect of oxytocin on speciﬁc brain
regions (Wang et al., 2017; Wigton et al., 2015) have discussed re-
sponse to facial emotions but have not separately analysed neuroima-
ging data for the eﬀect of oxytocin speciﬁc to facial emotion response
tasks. Given the importance of neural processing of facial emotion to
emotion recognition and social cognition, we believe the speciﬁc eﬀects
of oxytocin in healthy subjects was an important consideration war-
ranting further exploration and therefore performed this review. Fur-
ther, we wished to consider diﬀerential outcomes with the use of im-
plicit vs explicit paradigms for facial emotion recognition. Finally, we
wished to consider mediating roles of eye gaze, which was examined in
some of the studies, and has been suggested to play an important role in
processing of facial emotion, and polymorphisms of OXTR, which are
thought to inﬂuence the eﬀect of oxytocin.
As expected, there were signiﬁcant eﬀects of oxytocin in all studies
identiﬁed, with evidence for modulation by oxytocin of key social brain
regions, including during processing of direct vs indirect eye gaze. Also
as expected, given previous research on oxytocin, these eﬀects were
mediated by other factors, including sex and emotion type, in many of
the studies. Comparison of implicit vs explicit paradigms however did
not reveal a clear pattern of diﬀerential eﬀects.
4.1. Diﬀerential eﬀects of oxytocin relative to brain region and hemisphere
The most frequently identiﬁed region for eﬀects of oxytocin on
brain activity was the amygdala (twelve studies). This was not un-
expected, given the key role the amygdala has been shown to play in
social brain function (Adolphs, 2010; Heim et al., 2009) and evidence
for direct action of oxytocin in the amygdala (Heinrichs et al., 2009;
Landgraf and Neumann, 2004). It is worth noting however that all of
these studies, except Domes et al. (2010), used the amygdala for region
of interest (ROI) analysis, which may have biased the results. In con-
trast, other brain regions were mostly identiﬁed when whole brain
analysis (WBA) was employed.
In three studies (Domes et al., 2010; Kirsch et al., 2005; Spengler
et al., 2017), eﬀects were observed exclusively in the left amygdala; in
ﬁve (Bertsch et al., 2013; Domes et al., 2007; Kanat et al., 2015a;
Quintana et al., 2016; Radke et al., 2017), eﬀects were observed ex-
clusively in the right amygdala; while in three others (Gamer et al.,
2010; Kanat et al., 2015b; Shin et al., 2015) eﬀects were observed in
bilateral amygdalae. There is some evidence to suggest lateralisation of
amygdala in relation to social brain function in humans. For example,
(Murray, 2007) suggested a role for the left amygdala in the reward
system. A review of previous studies of the role of the amygdala in
facial emotion recognition, while yielding some apparently conﬂicting
results, concluded that unconscious (masked) processing is mediated
more readily by the right amygdala, and conscious processing more
readily by the left amygdala (Markowitsch, 1999). This factor may help
to explain the apparent discrepancy across studies, as all three studies
with ﬁndings exclusively in left amygdala used explicit paradigms
(though studies with signiﬁcant ﬁndings in right and bilateral amyg-
dalae used both implicit and explicit tasks). In relation to speciﬁc type
of emotion, Lanteaume et al. (2007) found that the left amygdala, when
stimulated, induced positive emotions, while the right amygdala in-
duced negative emotion. This would not explain the disparity of
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ﬁndings in our review however, as activations were found for both
positive and negative emotions in both left and right amygdalae.
Gamer et al. (2010) report more speciﬁc neuroanatomical localisa-
tion within the amygdala than in the other studies, identifying lateral
and dorsal regions of the anterior amygdala as having localised activity.
In healthy humans, functional neuroimaging studies have helped elu-
cidate diﬀerential roles for amygdala subregions in diﬀerent sensory
modalities (Morris et al., 2001), diﬀerent valences of auditory stimuli
(Ball et al., 2007; Frühholz and Grandjean, 2013), functional con-
nectivity in generalised anxiety disorder (Etkin et al., 2009), and re-
sponse to SSRIs in social anxiety disorder (Faria et al., 2012). In psy-
chopathy, a model of diﬀerential amygdala activation has been
described in which the basolateral amygdala (BLA) is underactive while
the activity of the central amygdala (CeA) is of average to above
average levels (Moul et al., 2012). Related to facial emotion recogni-
tion, Goosens et al., localised facial expression-evoked signal changes
bilaterally in the superﬁcial amygdala, in contrast to non-social visual
stimuli (Goossens et al., 2009), suggesting that this subregion selec-
tively extracts the social value of incoming sensory information. Hence,
diﬀerentiating simply between right and left amygdala response may
not be suﬃciently discriminating in relation to eﬀects of oxytocin on
brain function. Further, oxytocin also appears to reduce connectivity
between the amygdala and both cortical (insula and mid/dorsal ACC;
Gorka et al., 2015) and brainstem (Kirsch et al., 2005) regions in
healthy men, suggesting that oxytocin's eﬀects may be in part through
modulation of both top-down and bottom-up processes involving the
amygdala.
The fusiform gyrus was also implicated in a number of studies
(Domes et al., 2014; Domes et al., 2010; Kanat et al., 2015b; Petrovic
et al., 2008; Sauer et al., 2012). It has been suggested that the role of
the fusiform gyrus is speciﬁc to facial emotion recognition (Parvizi
et al., 2012) and this has been the most consistently activated brain
region in response to tasks incorporating facial stimuli (Wigton et al.,
2015). Other regions of the temporal lobe were also implicated, in-
cluding the anterior and medial temporal lobe (Petrovic et al., 2008),
the superior temporal gyrus (Domes et al., 2010; Voorthuis et al., 2014)
and the middle temporal gyrus (Domes et al., 2007; Domes et al., 2010;
Voorthuis et al., 2014; Wittfoth-Schardt et al., 2012). As the meta-
analysis by Wigton et al. (2015) demonstrated, overall, oxytocin ap-
pears to have sex-mediated eﬀects in the temporal lobes, with increased
activation in the temporal lobes in women and generally attenuated
activation in the temporal lobes in men.
The anterior cingulate cortex (ACC) was impacted by oxytocin in
two studies (Kanat et al., 2015a; Labuschagne et al., 2012). While the
ACC plays an important role in cognitive tasks such as choice prediction
(Kennerley et al., 2011), it has also been shown to be recruited in tasks
such as emotional recall imagery and emotional tasks with cognitive
demand (Phan et al., 2002). Oxytocin attenuated ACC activity in re-
sponse to negative emotions in both studies, suggesting oxytocin in-
ﬂuences top-down cortical modulation of response to emotional faces in
the ACC. Activity in the insula has also been previously associated with
emotion regulation (Phan et al., 2002), and left insular hyperactivation
after oxytocin administration has been demonstrated by a recent meta-
analysis (Wigton et al., 2015). However, the role of the insula appears
to be primarily related to modulation of risk prediction and reward
anticipation in a social context (Wigton et al., 2015). In our review,
only one study (Domes et al., 2010) implicated the insula, demon-
strating left insular activation in response to fearful, angry and happy
faces. This study was with female subjects, but had a small sample (n =
16), and so inferences about sex-speciﬁc eﬀects of oxytocin on the in-
sula in processing facial emotion are of limited value.
Taken together, these studies emphasise the importance of a more
nuanced understanding of brain regions involved in facial emotion re-
cognition, particularly the amygdala. As functional imaging metho-
dology and resolution continues to develop, improved anatomical
speciﬁcity of functional imaging may help resolve uncertainties about
speciﬁc eﬀects of oxytocin on individual emotions. A further con-
sideration is the use of ROI analysis in these studies. Given that many of
the studies implicated regions other than the amygdala as being im-
portant to oxytocin's eﬀects, it no longer seems appropriate to identify
the amygdala as the sole region of interest in future study designs.
4.2. Diﬀerential eﬀects of oxytocin relative to emotion, sex and implicit vs
explicit paradigms
Oxytocin's eﬀects on the brain appear to be dependent in part on the
speciﬁc emotion in question. In all studies involving male subjects that
reported neural responses to facial expression of speciﬁc emotions,
except one (Domes et al., 2014), oxytocin reduced amygdala activity in
response to fearful faces. This is in keeping with meta-analyses of
functional neuroimaging studies in normal subjects, which have con-
sistently demonstrated involvement of the amygdala in processing of
fear (Murphy et al., 2003; Phan et al., 2002). One possible explanation
for modulation by oxytocin is an anxiolytic eﬀect, which has been de-
monstrated by numerous animal (Amico et al., 2004; Engelmann et al.,
1999; Ring et al., 2006; Waldherr and Neumann, 2007; Yoshida et al.,
2009) and some human (Guastella et al., 2009; Labuschagne et al.,
2010) studies, and is likely to be amygdala-mediated (Viviani et al.,
2011, 2010). This would suggest a potential modulatory role for oxy-
tocin in impaired regulation of facial emotion processing in anxiety
disorders, which has been demonstrated in both adults (Demenescu
et al., 2010; Goldin et al., 2009) and adolescents (McClure et al., 2014).
Indeed, in their subjects with generalised anxiety disorder,
Labuschagne et al. (2012) demonstrated that oxytocin signiﬁcantly
reduced heightened activation at baseline in the mPFC/ACC regions to
levels similar to that of controls. Furthermore, as impaired fear re-
cognition is thought to be an important factor in antisocial personality
disorder (with and without psychopathy) (Blair, 2006; Dolan and
Fullam, 2006; Marsh and Blair, 2008), modulation by oxytocin may also
have therapeutic value for these disorders. This may be particularly
relevant to individuals with antisocial personality disorder without
psychopathy, who demonstrate a hyperactive amygdala at baseline
(Blair, 2010).
The pattern of attenuation of amygdala responsivity by oxytocin in
response to fearful faces extended to angry (Domes et al., 2007; Kanat
et al., 2015a; Kirsch et al., 2005) and sad (Labuschagne et al., 2012)
faces in other studies in males. In contrast, in response to happy faces,
ﬁndings for the eﬀects of oxytocin on the amygdala were mixed, with
both attenuation (Domes et al., 2007; Quintana et al., 2016; Shin et al.,
2015) and enhancement (Gamer et al., 2010; Labuschagne et al., 2012)
being demonstrated. This apparent discrepancy reﬂects inconsistencies
from behavioural studies (Shahrestani et al., 2013) and warrants fur-
ther exploration. Diﬀerences in facial emotion paradigms may be a
contributory factor, as discussed below.
Oxytocin's eﬀects also appear to be mediated by sex diﬀerences. In
females, as in males, enhancement of activity was seen in response to
happy faces (Domes et al., 2010; Groppe et al., 2013). However, in
contrast to males, oxytocin also enhanced neural activity in the
amygdala (Bertsch et al., 2013; Domes et al., 2010) and superior tem-
poral gyrus and fusiform gyrus (Domes et al., 2010) in response to
fearful faces, and in inferior frontal gyrus in response to angry faces
(Domes et al., 2010). Luo et al. (2017) showed that while oxytocin
suppressed brain activity in inferior frontal gyrus, dorsal anterior cin-
gulate and anterior insula in response to threatening face stimuli in
males, it increased them in females. Further, this study showed further
sex-dependent eﬀects in functional connectivity (see Table 1) that were
mainly driven by reduced coupling in women following oxytocin.
There are several potential explanations for the apparent diﬀer-
ential eﬀects of oxytocin on response to facial emotion in men and
women. Although oxytocin modulates both salience and motivational
aspects of social cues in both sexes (McCall and Singer, 2012), sex has
been shown to moderate the eﬀect of oxytocin on social judgments
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(Hoge et al., 2014), autonomic nervous system and emotional responses
to couple conﬂict (Ditzen et al., 2012), and amygdala response to social
judgements (Gao et al., 2016). Hence, sex is also likely to modulate
response to facial emotions, another form of social cue. Further, meta-
analysis has demonstrated diﬀerences in amygdala responsivity to
emotions between men and women at baseline, with women demon-
strating greater activation than men in response to negative emotions,
particularly in the amygdala, and men exhibiting greater activation
than women in the left amygdala, and other regions (Stevens and
Hamann, 2012). Also, higher levels of progesterone in women (espe-
cially in luteal phase of menstrual cycle), are associated with enhanced
sensitivity to fearful faces at baseline, and it may be that intranasal
oxytocin further enhances vigilance to signals of potential threat
(Domes et al., 2010). Finally, diﬀerences in the sensitivity of the oxy-
tocin system to exogenous oxytocin between women and men could be
due to modulations by gonadal steroids. Women diﬀer from men in the
luteal phase with regard to gonadal steroid hormones (Hawkins and
Matzuk, 2008), thus providing a plausible explanation for inconsistent
ﬁndings between men and women.
Debate persists about whether implicit or explicit responses to
emotion are optimal measures of facial emotional processing, and many
argue that they should be conceptualised and measured separately
(Braunstein et al., 2017; Kliemann et al., 2013). Further, evidence
suggests that implicit and explicit processing may have distinct neural
substrates, with amygdala and subcortical limbic activity important for
the implicit process and the response of the prefrontal cortex for the
explicit process (Critchley et al., 2000; Xiao et al., 2016). Our analysis
of outcomes based on implicit vs explicit facial emotion paradigms
(Table 2) did not reveal any consistent pattern of ﬁndings. Most no-
tably, amygdala activation was shown in both males and females using
implicit tasks and explicit tasks, while no amygdala activation was
observed in other studies using implicit (Domes et al., 2014; Groppe
et al., 2013) or explicit (Koch et al., 2016b) tasks. Currently, evidence
for diﬀering patterns of oxytocin modulation based on type implicit vs
explicit paradigm remains equivocal. Future studies may beneﬁt how-
ever from delineating implicit and explicit brain response.
4.3. Diﬀerential eﬀects of oxytocin relative to gaze processing
Eye gaze is a central component of identiﬁcation of human facial
emotion (Haxby et al., 2002; Smith et al., 2005). Impairments in eye
gaze have been associated with deﬁcits in facial emotion processing,
particularly in autism (Guastella et al., 2008). While both averted- and
direct-gaze faces are ‘social’ stimuli, in direct gaze, attention is toward
the individual, while in averted gaze, the attention is directed toward
an extrapersonal spatial location. Thus, it has been suggested that direct
gaze is more socially relevant (Haxby et al., 2002; Petrovic et al., 2008).
Intranasal oxytocin has been shown gaze speciﬁcally toward the eye
region of human faces (Guastella et al., 2008), while a more recent
study demonstrated that oxytocin diﬀerentially modulates eye gaze to
social signals (Domes et al., 2013).
Four of the six studies which examined eye gaze processing studies
showed an inﬂuence of oxytocin on related brain activity. Three
(Bertsch et al., 2013; Gamer et al., 2010; Petrovic et al., 2008) showed
modulation of the amygdala, while two (Petrovic et al., 2008; Sauer
et al., 2012) implicated the fusiform gyrus. Together, these ﬁndings are
in keeping with previous research, showing that fusifrom gyrus acti-
vation is related to processing of direct relative to averted gaze (George
et al., 2001), and that amygdala activation has been shown to predict
gaze toward fearful eyes (Gamer and Büchel, 2009) and associated with
analysis of gaze cues when a person is actively monitoring for emo-
tional gaze events (Hooker et al., 2003). Based on existing evidence, a
model may be proposed whereby oxytocin modulates facial emotion
recognition in part by activating the amygdala and fusiform gyrus to
direct gaze shift towards the eye region. This model would beneﬁt from
further investigation using standardised measures of eye gaze and
amygdala activation. Of note however, one more recent study showed
no eﬀect of oxytocin of gaze ﬁxation (Lischke et al., 2012b).
4.4. Diﬀerential eﬀects of oxytocin relative to genotype
There is now a robust body of evidence demonstrating eﬀects of
variation in the oxytocin receptor gene (OXTR) on a range of psychia-
tric conditions and behavioural measures (Bakermans-Kranenburg and
van IJzendoorn, 2014; Meyer-Lindenberg et al., 2011). Both studies in
our review examining eﬀect of genotype (Montag et al., 2013; Sauer
et al., 2012) demonstrated that variations in a single nucleotide poly-
morphisms (SNP) of OXTR (rs3796863 and rs401015 respectively) had
a signiﬁcant inﬂuence on and neuronal measures of facial emotion/
social processing. In Sauer et al., homozygotic risk allele carriers
showed slower reaction times and higher activation of left fusiform
gyrus during visual processing of social stimuli. Oxytocin appeared to
modulate this eﬀect by enhancing activation diﬀerences between allele
groups. Although Montag et al. (2013) did not observe a main eﬀect of
gaze direction on amygdala activity, genetic variation of the OXTR gene
(rs401015) modulated right amygdala activity for direct> averted
gaze under inﬂuence of OT.
Since these studies were published, novel methods (Chiu and Miller,
2016) and large-scale multicentre trials (Ripke et al., 2014) have come
increasingly to the fore of molecular genetic research. Future studies
examining the impact of genotype on the role of oxytocin will beneﬁt
from such approaches, which are more likely to contribute towards
causal associations between genotype and neuroimaging and beha-
vioural measures. Studies examining eﬀects of individuals SNPs have
yielded the most promising results when focusing on biological mea-
sures such as neuroimaging parameters (Bakermans-Kranenburg and
van IJzendoorn, 2014). These are more likely to be successful than
those focusing on more distal, complex social phenotypes with error-
prone assessments (Bakermans-Kranenburg and van IJzendoorn, 2014).
4.5. Other considerations
It should be noted that many of the studies included in this review
had small sample size (average 36.5 per group of healthy subjects) and
while power calculations were inconsistently reported, many studies
were likely signiﬁcantly underpowered. The issue of low statistical
power is a well-recognised criticism in both neuroimaging research
(Button et al., 2013; Ioannidis, 2005) and studies involving oxytocin
generally (Walum et al., 2016). Studies with low statistical power in-
crease the likelihood of both type I and type II errors, producing poor
quality research with ethical implications (Button et al., 2013). Factors
which may address the issue of low statistical power include a priori
power calculations, transparent disclosure of methods and ﬁndings
where null ﬁndings are demonstrated, pre-registration of study proto-
cols and analysis plans, and making study materials and data available,
and working collaboratively to increase power and replicate ﬁndings
(Button et al., 2013). Further, recent attempts for clearer guidance on
power calculation (Durnez et al., 2016) and task design (Durnez et al.,
2017) in fMRI studies should help improve quality of research in this
area. It is notable that the GRADE score allocated by this review of 1
translates to ‘very low quality’ research, with particular problems due
to sparse data, methodological concerns, and lack of agreement be-
tween studies.
A further consideration is the potential for publication bias in the
published literature. Traditionally, meta-analysis can overcome the
issue of statistical power, and can be used to assess publication bias.
However, many of the studies returned from this review performed ROI
analyses, which cannot be combined with whole-brain analyses in
methodologically sound neuroimaging meta-analysis (Radua et al.,
2012). Furthermore, meta-analysis requires that the contrasts in in-
dividual studies are testing similar constructs – in the current review,
there were a relatively low number of studies (ﬁve) which could be
J. Tully et al. Psychiatry Research: Neuroimaging 272 (2018) 17–29
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grouped together. As such, a meta-analysis was not considered a
worthwhile addition in this instance.
In conclusion, oxytocin modulates facial emotion processing in key
‘social brain’ areas in normal adults. This eﬀect is mediated by in-
dividual diﬀerences, including sex and genotype. The evidence for
diﬀerential response to facial emotions (with or without oxytocin) re-
lative to implicit vs explicit tasks remains equivocal. Oxytocin's eﬀects
may be exerted in part through enhanced gaze processing, involving the
amygdala and fusiform gyrus. Research in this area to date has been
somewhat limited by low statistical power, methodological hetero-
geneity, and a dearth of multimodal studies. Future studies should en-
sure controls for individual diﬀerences, including sex, physiology, and
genotype. Further work will beneﬁt from accurate and transparent
power calculation, collaborative projects involving genotyping and
other methodologies.
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